LANGER ROBERT

CIK 00012397575 companiesMARLBOROUGH, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001239757

Recent Transactions

48 trades

Award
Ocata Therapeutics, Inc.
Common Stock
2015-09-30+1,250→ 51,000 total
Award
Ocata Therapeutics, Inc.
Common Stock
2015-09-30+1,250→ 51,000 total
Award
Ocata Therapeutics, Inc.
Stock Option (Right to Buy)
2015-01-02+5,000→ 5,000 total
Award
Ocata Therapeutics, Inc.
Stock Option (Right to Buy)
2015-01-02+5,000→ 5,000 total
Award
Ocata Therapeutics, Inc.
Common Stock
2014-12-31+1,250→ 47,250 total
Award
Ocata Therapeutics, Inc.
Common Stock
2014-12-31+1,250→ 47,250 total
Award
Ocata Therapeutics, Inc.
Common Stock
2014-09-30+1,250→ 46,000 total
Award
Ocata Therapeutics, Inc.
Common Stock
2014-09-30+1,250→ 46,000 total
Award
Ocata Therapeutics, Inc.
Stock Option (Right to Buy)
2014-01-02+500,000→ 500,000 total
Award
Ocata Therapeutics, Inc.
Stock Option (Right to Buy)
2014-01-02+500,000→ 500,000 total
Award
Ocata Therapeutics, Inc.
Common Stock
2013-12-31+125,000→ 4,225,000 total
Award
Ocata Therapeutics, Inc.
Common Stock
2013-12-31+125,000→ 4,225,000 total
Sale
INVIVO THERAPEUTICS HOLDINGS CORP.
COMMON STOCK, $0.00001 PAR VALUE
2011-12-29$2.49/sh−165,247→ 8,097,113 total
Sale
INVIVO THERAPEUTICS HOLDINGS CORP.
COMMON STOCK, $0.00001 PAR VALUE
2011-12-29$2.49/sh−165,247→ 8,097,113 total
Sale
MOMENTA PHARMACEUTICALS INC
Common Stock
2008-08-08$16.81/sh−20,000→ 950,022 total
Sale
MOMENTA PHARMACEUTICALS INC
Common Stock
2008-08-08$16.81/sh−20,000→ 950,022 total
Award
WYETH
Common Stock
2008-01-02+800→ 4,000 total
Award
WYETH
Common Stock
2008-01-02+800→ 4,000 total
Award
MOMENTA PHARMACEUTICALS INC
Common Stock
2007-09-13+16,000→ 970,022 total
Award
MOMENTA PHARMACEUTICALS INC
Common Stock
2007-09-13+16,000→ 970,022 total
Award
WYETH
Common Stock
2007-01-02+800→ 3,200 total
Award
WYETH
Common Stock
2007-01-02+800→ 3,200 total
Award
WYETH
Non-Employee Director Stock Option
2006-04-27+3,500→ 3,500 total
Award
WYETH
Common Stock (Restricted Stock Trust)
2006-04-27+1,200→ 1,200 total
Award
WYETH
Non-Employee Director Stock Option
2006-04-27+3,500→ 3,500 total
Award
WYETH
Common Stock (Restricted Stock Trust)
2006-04-27+1,200→ 1,200 total
Award
WYETH
Common Stock
2006-01-02+800→ 2,400 total
Award
WYETH
Common Stock
2006-01-02+800→ 2,400 total
Gift
MOMENTA PHARMACEUTICALS INC
Common Stock
2005-06-03−21,740→ 954,022 total
Gift
MOMENTA PHARMACEUTICALS INC
Common Stock
2005-06-03−21,740→ 954,022 total
Award
Echo Therapeutics, Inc.
Director Stock Option (right to buy)
2005-05-24+25,000→ 25,000 total
Award
Echo Therapeutics, Inc.
Director Stock Option (right to buy)
2005-05-24+25,000→ 25,000 total
Award
WYETH
Non-Employee Director Stock Option
2005-04-21$43.57/sh+4,000→ 4,000 total
Award
WYETH
Non-Employee Director Stock Option
2005-04-21$43.57/sh+4,000→ 4,000 total
Award
WYETH
Common Stock
2005-01-03+800→ 1,600 total
Award
WYETH
Common Stock
2005-01-03+800→ 1,600 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-26−33,333→ 0 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-26−33,333→ 0 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-26+35,211→ 500,041 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-26+35,211→ 500,041 total
Award
WYETH
Non-Employee Director Stock Option
2004-04-22+4,000→ 4,000 total
Award
WYETH
Non-Employee Director Stock Option
2004-04-22+4,000→ 4,000 total
Award
WYETH
Common Stock
2004-01-02+800→ 800 total
Award
WYETH
Common Stock
2004-01-02+800→ 800 total
Purchase
Echo Therapeutics, Inc.
Series A Convertible Preferred Stock
2003-09-15$1.00/sh+33,333→ 33,333 total
Purchase
Echo Therapeutics, Inc.
Series A Convertible Preferred Stock
2003-09-15$1.00/sh+33,333→ 33,333 total
Purchase
Echo Therapeutics, Inc.
Common Stock Purchase Warrants(right to buy)
2003-09-15+33,333→ 33,333 total
Purchase
Echo Therapeutics, Inc.
Common Stock Purchase Warrants(right to buy)
2003-09-15+33,333→ 33,333 total

Companies

Recent Filings

Address

33 LOCKE DRIVE C/O OCATA THERAPEUTICS, INC.

MARLBOROUGH, MA, 01752

View on SEC.gov